Previous Close | 2.6500 |
Open | 2.6500 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 135.00 |
Expire Date | 2024-06-21 |
Day's Range | 2.6500 - 2.6500 |
Contract Range | N/A |
Volume | |
Open Interest | 196 |
Quest Diagnostics Incorporated (NYSE: DGX), a leader in diagnostic information services, announced that it will report second quarter 2024 financial results on Tuesday, July 23, 2024, before the market opens. It will hold its quarterly conference call to discuss the results beginning at 8:30 a.m. Eastern Time on that day.
Quest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption of AI and digital pathology to improve cancer diagnosis.
NORTHAMPTON, MA / ACCESSWIRE / June 12, 2024 / Quest Diagnostics I've spent most of my career working in an industry where lives are on the line. Prior to coming to Quest Diagnostics, I worked in transportation in the airline industry as a ramp agent. ...